Form 4: Innoviva Director Sarah J. Schlesinger Reports Stock and Option Grant
SEC Form 4 Filing
Director Sarah J. Schlesinger reports acquisition of Innoviva stock and options following the company's annual meeting.
Summary
- On June 17, 2024, Sarah J. Schlesinger, a director of Innoviva, Inc., reported changes in her beneficial ownership of the company's securities.
- Schlesinger acquired 13,923 shares of common stock and 10,000 non-statutory stock options.
- The stock was acquired at a price of $0.
- The options have an exercise price of $16.16 and expire on June 16, 2034.
- These transactions occurred following the conclusion of Innoviva's 2024 annual meeting of stockholders.
- The restricted stock units (RSUs) and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of the grant, contingent upon continuous service as an Outside Director.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock and option grants to a director, indicating alignment of interests but not necessarily a strong positive or negative signal.
Positives
- The acquisition of stock and options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
- The vesting schedule tied to continued service aligns the director's interests with those of the shareholders.
Future Outlook
The vesting of the RSUs and options is contingent upon the director's continuous service, suggesting an ongoing commitment to the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Comparison to Industry Standards
- Director compensation packages often include stock options and restricted stock units to align their interests with shareholders, a common practice across publicly traded companies.
- The vesting schedule of one year or the next annual meeting is a typical arrangement for director equity grants.
Stakeholder Impact
- Shareholders can view the director's acquisition of stock and options as a sign of confidence in the company's future prospects.
- The vesting schedule incentivizes the director to remain engaged and contribute to the company's success.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of transaction: Acquisition of common stock and stock options. |
| 06/17/2025 | Earliest vesting date for RSUs and options, contingent on continued service. |
| 06/16/2034 | Expiration date of the non-statutory stock options. |
| 06/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.